The SARS-CoV-2 Delta (B.1.617.2) variant with spike N501Y mutation in the shadow of Omicron emergence

被引:0
|
作者
Salimovic-Besic, Irma [1 ]
Dedeic-Ljubovic, Amela [1 ]
Zahirovic, Edina [1 ]
Hasanovic, Medina [1 ]
Sehic, Merima [1 ]
Vukovikj, Maja [2 ]
Boshevska, Golubinka [3 ]
Vegar-Zubovic, Sandra [1 ]
Mehmedika-Suljic, Enra [1 ]
Izetbegovic, Sebija [1 ]
机构
[1] Univ Sarajevo, Clin Ctr, Bolnicka 25, Sarajevo 71000, Bosnia & Herceg
[2] Inst Publ Hlth Republ North Macedonia, 50-Ta Div 6, Skopje 1000, North Macedonia
[3] Univ Goce Delchev, Fac Med Sci, Krste Misirkov 10-A POB 201, Shtip 2000, North Macedonia
关键词
SARS-CoV-2; N501Y; Delta variant; Omicron variant; COVID-19; Pandemic; Spike protein; RECEPTOR-BINDING DOMAIN; ACCURATE; ACE2;
D O I
10.1016/j.heliyon.2022.e12650
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Circulation of the Omicron variant with the reemergence of the N501Y mutation along with many others in the spike protein has once again stirred the academic community. Interestingly, tracing the genetic diversity of SARS-CoV-2 shed light on a less frequent N501Y + Delta variant which has been in the global circulation for some time before the Omicron appearance. This paper aims to present the molecular characteristics of the SARS-CoV-2 Spike_N501Y + Delta variant detected in Bosnia and Herzegovina. The study was conducted during November and December 2021. All patients were tested using real-time RT-PCR for detection of SARS-CoV-2. A representative number of SARS-CoV-2 positive samples was pre-screened using VirSNiP SARS-CoV-2 Spike N501Y kit. The characterization of the viruses was carried out with Illumina RNA Prep with enrichment and the Respiratory Virus Oligo Panel kit. Among the analyzed sequences, we found two isolates of the Delta variant that differ from their most related clade- GK AY.4.3 in additional mutations N501Y and L54F. In this study, we described the presence of a rare form of Delta variant with Spike_N501Y mutation in the shadow of the Omicron emergence. Despite the set of mutations in the Spike protein, this form of Delta variant does not indicate the large-scale consequences for the general population. Further functional studies of this form could provide more information about its antigenicity and infectivity.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] The evaluation of potential global impact of the N501Y mutation in SARS-COV-2 positive patients
    Komurcu, Selen Zeliha Mart
    Artik, Yakup
    Cesur, Nevra Pelin
    Tanriverdi, Arzu
    Erdogan, Derya Cakir
    Celik, Sule
    Gulec, Elif Yilmaz
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (03) : 1009 - 1019
  • [42] First Detection of SARS-CoV-2 Delta (B.1.617.2) Variant of Concern in a Dog with Clinical Signs in Spain
    Fernandez-Bastit, Leira
    Rodon, Jordi
    Pradenas, Edwards
    Marfil, Silvia
    Trinite, Benjamin
    Parera, Mariona
    Roca, Nuria
    Pou, Anna
    Cantero, Guillermo
    Lorca-Oro, Cristina
    Carrillo, Jorge
    Izquierdo-Useros, Nuria
    Clotet, Bonaventura
    Noguera-Julian, Marc
    Blanco, Julia
    Vergara-Alert, Julia
    Segales, Joaquim
    VIRUSES-BASEL, 2021, 13 (12):
  • [43] Genomic Surveillance Tracks the First Community Outbreak of the SARS-CoV-2 Delta (B.1.617.2) Variant in Brazil
    Lamarca, Alessandra P.
    de Almeida, Luiz G. P.
    Francisco, Ronaldo da Silva, Jr.
    Cavalcante, Liliane
    Machado, Douglas Terra
    Brustolini, Otavio
    Gerber, Alexandra L.
    Guimaraes, Ana Paula de C.
    Policarpo, Cintia
    de Oliveira, Gleidson da Silva
    Boullosa, Lidia Theodoro
    de Souza, Isabelle Vasconcellos
    de Carvalho, Erika Martins
    Ribeiro, Mario Sergio
    Carvalho, Silvia
    da Silva, Flavio Dias
    Garcia, Marcio Henrique de Oliveira
    de Souza, Leandro Magalhaes
    Da Silva, Cristiane Gomes
    Ribeiro, Caio Luiz Pereira
    Cavalcanti, Andrea Cony
    de Mello, Claudia Maria Braga
    Tanuri, Amilcar
    Vasconcelosa, Ana Tereza R.
    JOURNAL OF VIROLOGY, 2022, 96 (02)
  • [44] Infection and Transmission of SARS-CoV-2 B.1.617.2 Lineage (Delta Variant) among Fully Vaccinated Individuals
    Caserta, Leonardo C.
    Martins, Mathias
    Cronk, Brittany
    Anderson, Renee
    Eldridge, Harry
    Gallow, Deidre
    Kruppa, Frank
    Plocharczyk, Elizabeth
    Diel, Diego G.
    MICROBIOLOGY SPECTRUM, 2022, 10 (05):
  • [45] Severe breakthrough COVID-19 cases in the SARS-CoV-2 delta (B.1.617.2) variant era
    Wang, Stephen Y.
    Juthani, Prerak, V
    Borges, Kelly A.
    Shallow, Marcus K.
    Gupta, Akash
    Price, Christina
    Won, Christine H.
    Chun, Hyung J.
    LANCET MICROBE, 2022, 3 (01): : E4 - E5
  • [46] Entropic Overcompensation of the N501Y Mutation on SARS-CoV-2 S Binding to ACE2
    Vergara, Natasha Gupta
    Gatchel, Megan
    Abrams, Cameron F.
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2022, 63 (02) : 633 - 642
  • [47] Effectiveness of REGEN-COV antibody cocktail against the B.1.617.2 (delta) variant of SARS-CoV-2: A cohort study
    Jagadeesh, Kumar, V
    Banu, Sofia
    Sasikala, Mitnala
    Parsa, Kishore V. L.
    Sowpati, Divya Tej
    Yadav, Rupali
    Tallapaka, Karthik Bharadwaj
    Siva, Archana Bharadwaj
    Vishnubhotla, Ravikanth
    Rao, G. V.
    Reddy, Duvvur Nageshwar
    JOURNAL OF INTERNAL MEDICINE, 2022, 291 (03) : 380 - 383
  • [48] Emergence of SARS-CoV-2 lineage B.1.617.2 in the local community of Hong Kong
    Tsang, Alan K. L.
    Mak, Gannon C. K.
    Leung, Patricia K. L.
    Cheng, Peter K. C.
    Yip, Peter C. W.
    Lam, Edman T. K.
    Ng, Ken H. L.
    Chan, Rickjason C. W.
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (01) : 29 - 31
  • [49] Mutation-induced changes in the receptor-binding interface of the SARS-CoV-2 Delta variant B.1.617.2 and implications for immune evasion
    Baral, Prabin
    Bhattarai, Nisha
    Hossen, Md Lokman
    Stebliankin, Vitalii
    Gerstman, Bernard S.
    Narasimhan, Giri
    Chapagain, Prem P.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 574 : 14 - 19
  • [50] Case series in Indonesia: B.1.617.2(delta) variant of SARS-CoV-2 infection after a second dose of vaccine
    Anis Karuniawati
    Ari F Syam
    Armand Achmadsyah
    Fera Ibrahim
    Yulia Rosa
    Pratiwi Sudarmono
    Fadilah Fadilah
    Menaldi Rasmin
    World Journal of Clinical Cases, 2022, (36) : 13216 - 13226